Andrea Jacobs
Overview
Explore the profile of Andrea Jacobs including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
2212
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wegmann R, Bonilla X, Casanova R, Chevrier S, Coelho R, Esposito C, et al.
Nat Commun
. 2024 Oct;
15(1):9402.
PMID: 39477946
Deep single-cell multi-omic profiling offers a promising approach to understand and overcome drug resistance in relapsed or refractory (rr) acute myeloid leukemia (AML). Here, we combine single-cell ex vivo drug...
2.
Powell T, Tang J, Mitchell R, DeRome M, Jacobs A, Palath N, et al.
Vaccines (Basel)
. 2023 Dec;
11(12).
PMID: 38140193
We previously reported a protective antibody response in mice immunized with synthetic microparticle vaccines made using layer-by-layer fabrication (LbL-MP) and containing the conserved T1BT* epitopes from the circumsporozoite protein. To...
3.
Powell T, Jacobs A, Tang J, Cardenas E, Palath N, Daniels J, et al.
Vaccines (Basel)
. 2022 Dec;
10(12).
PMID: 36560488
Layer-by-layer microparticle (LbL-MP) fabrication was used to produce synthetic vaccines presenting a fusion peptide containing RSV G protein CX3C chemokine motif and a CD8 epitope of the RSV matrix protein...
4.
Crowell H, Chevrier S, Jacobs A, Sivapatham S, Bodenmiller B, Robinson M
F1000Res
. 2022 Sep;
9:1263.
PMID: 36072920
Mass cytometry (CyTOF) has become a method of choice for in-depth characterization of tissue heterogeneity in health and disease, and is currently implemented in multiple clinical trials, where higher quality...
5.
Jacobs A, Williams D, Hickey K, Patrick N, Williams A, Chalk S, et al.
J Chem Inf Model
. 2022 May;
62(11):2737-2743.
PMID: 35559614
CAS Common Chemistry (https://commonchemistry.cas.org/) is an open web resource that provides access to reliable chemical substance information for the scientific community. Having served millions of visitors since its creation in...
6.
De Vargas Roditi L, Jacobs A, Rueschoff J, Bankhead P, Chevrier S, Jackson H, et al.
Cell Rep Med
. 2022 May;
3(4):100604.
PMID: 35492239
Localized prostate cancer exhibits multiple genomic alterations and heterogeneity at the proteomic level. Single-cell technologies capture important cell-to-cell variability responsible for heterogeneity in biomarker expression that may be overlooked when...
7.
Wagner J, Masek M, Jacobs A, Soneson C, Sivapatham S, Damond N, et al.
Sci Data
. 2022 Feb;
9(1):44.
PMID: 35140234
Epithelial-mesenchymal transition (EMT) equips breast cancer cells for metastasis and treatment resistance. However, detection, inhibition, and elimination of EMT-undergoing cells is challenging due to the intrinsic heterogeneity of cancer cells...
8.
Lu J, Cannizzaro E, Meier-Abt F, Scheinost S, Bruch P, Giles H, et al.
Nat Cancer
. 2021 Aug;
2(8):853-864.
PMID: 34423310
Chronic Lymphocytic Leukemia (CLL) has a complex pattern of driver mutations and much of its clinical diversity remains unexplained. We devised a method for simultaneous subgroup discovery across multiple data...
9.
Adamo S, Chevrier S, Cervia C, Zurbuchen Y, Raeber M, Yang L, et al.
Allergy
. 2021 Apr;
76(9):2866-2881.
PMID: 33884644
Background: Coronavirus disease 2019 (COVID-19) is caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and shows a broad clinical presentation ranging from asymptomatic infection to fatal disease....
10.
Chevrier S, Zurbuchen Y, Cervia C, Adamo S, Raeber M, de Souza N, et al.
Cell Rep Med
. 2021 Feb;
2(1):100166.
PMID: 33521697
Coronavirus disease 2019 (COVID-19) manifests with a range of severities, but immune signatures of mild and severe disease are still not fully understood. Here, we use mass cytometry and targeted...